Abeona Therapeutics Inc
NASDAQ:ABEO
Earnings Announcements
Abeona Therapeutics Inc Says Joseph Vazzano Has Been Appointed Chief Financial Officer
Published: 03/31/2022 11:42 GMT
Abeona Therapeutics Inc (ABEO) - Abeona Therapeutics Inc Says Joseph Vazzano Has Been Appointed Chief Financial Officer.
Abeona Therapeutics Inc - Qtrly Basic and Diluted Loss per Common Share $0.45.
Abeona Therapeutics Inc - Qtrly Basic and Diluted Loss per Common Share $0.45.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.08
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.07
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.08
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.07
More details on our Analysts Page.